+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Lead nephropathy, gout, and hypertension

Lead nephropathy, gout, and hypertension

American Journal of the Medical Sciences 305(4): 241-247

The EDTA (calcium disodium edetate) lead mobilization test revealed lead as the probable cause of renal disease in industrial lead workers and in patients with gout or essential hypertension. The data reviewed here demonstrate persistence of lead nephropathy in the contemporary scene despite the introduction of modern industrial and environmental exposure standards. Renal function and biopsy studies showed that lead nephropathy is a chronic tubulointerstitial renal disease with modest proteinuria which frequently presents with hyperuricemia, gout and hypertension. Only evaluation of body lead stores by either the EDTA lead mobilization test or by x-ray fluorescence is helpful in diagnosing lead nephropathy. While chelation therapy is safe and helpful in reversing early lead nephropathy, the best treatment is prevention. These studies further raise the possibility that chronic environmental lead poisoning and associated renal disease and hypertension may be a more widespread problem than suspected. Assessment of the true extent of chronic lead poisoning requires large scale epidemiological studies.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 032129442

Download citation: RISBibTeXText

PMID: 8475950

DOI: 10.1097/00000441-199304000-00008

Related references

Lead and the kidney: nephropathy, hypertension, and gout. Connecticut Medicine 60(9): 521-526, 1996

Triglyceride concentrations in primary gout and gout of chronic lead nephropathy. Metabolism: Clinical and Experimental 20(8): 721-729, 1971

Lead nephropathy and gout. American Journal of Kidney Diseases 2(5): 555-558, 1983

The role of lead in gout nephropathy. New England Journal of Medicine 304(9): 520-523, 1981

Bone lead measurement by x-ray fluorescence and its relationship with nephropathy in gout. Arthritis and Rheumatism 42(9 Suppl. ): S159, 1999

The role of lead in gout nephropathy reviewed: pathogenic or associated factor?. Advances in Experimental Medicine and Biology 309a: 209-212, 1991

Lead gout with giant tophi under the skin, nephropathy and porphyrinopathy. Zeitschrift für Hautkrankheiten 52(6): 346-347, 1977

Gout nephropathy and arterial hypertension. Przeglad Lekarski 42(3): 323-324, 1985

Chronic Lead Nephropathy: The Diagnostic Use Of Calcium Edta And The Association With Gout. Australasian Annals of Medicine 12: 310-324, 1963

Bone lead, hypertension, and lead nephropathy. Environmental Health Perspectives 78: 57-60, 1988

Clinical aspects of nephropathy in gout (based on 210 cases of gout). Reumatologia 12(4): 355-366, 1974

Subclinical lead poisoning as a cause of nephropathy and arterial hypertension. Polski Tygodnik Lekarski 42(18): 565-568, 1987

Hyperuricemia, gout and gout-induced nephropathy. Terapevticheskii Arkhiv 52(4): 133-142, 1980

The clinical differentiation of lead gout from primary gout. Arthritis and Rheumatism 11(5): 623-634, 1968